Research Article
Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-κB Signaling in Prostate Cancer
Table 1
Clinicopathological features of PC patients and their relationship with CXCL14 expression.
| | Characteristics | Cases (%) () | CXCL14 expression (%) | value | | Higher (≥50%) | Lower (<50%) |
| | Age | | <65 | 13 (46%) | 6 (46%) | 7 (54%) | 0.138 | | ≥65 | 15 (54%) | 8 (53%) | 7 (47%) | | Pathological stage | | T1 | 11 (39%) | 7 (64%) | 4 (36%) | 0.007 | | T2/T3 | 17 (61%) | 14 (82%) | 3 (18%) | | Lymph node metastasis | | Negative | 13 (46%) | 8 (62%) | 5 (38%) | 0.012 | | Positive | 15 (54%) | 11 (73%) | 4 (27%) | | Angiolymphatic invasion | | Negative | 16 (57%) | 9 (56%) | 7 (44%) | 0.028 | | Positive | 12 (43%) | 8 (67%) | 4 (33%) | | Preoperative PSA | | <4 ng/ml | 16 (57%) | 9 (56%) | 7 (44%) | 0.126 | | ≥4 ng/ml | 12 (42%) | 7 (58%) | 5 (42%) | | Gleason score | | <8 | 12 (43%) | 7 (58%) | 9 (42%) | 0.281 | | ≥8 | 16 (57%) | 6 (38%) | 6 (62%) |
|
|